Marcela Veronica Horvitz-Lennon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antipsychotic Agents | 27 | 2024 | 3057 | 4.010 |
Why?
|
Schizophrenia | 20 | 2023 | 6882 | 2.300 |
Why?
|
Mental Health Services | 16 | 2022 | 1643 | 1.800 |
Why?
|
Medicaid | 16 | 2022 | 2736 | 1.390 |
Why?
|
Clozapine | 3 | 2017 | 498 | 0.840 |
Why?
|
Medication Adherence | 4 | 2020 | 2063 | 0.830 |
Why?
|
Healthcare Disparities | 8 | 2023 | 3158 | 0.740 |
Why?
|
Risperidone | 3 | 2023 | 383 | 0.600 |
Why?
|
Diffusion of Innovation | 2 | 2012 | 725 | 0.540 |
Why?
|
Quality of Health Care | 7 | 2018 | 4371 | 0.540 |
Why?
|
Mental Disorders | 12 | 2021 | 6600 | 0.530 |
Why?
|
Delayed-Action Preparations | 1 | 2018 | 968 | 0.510 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.510 |
Why?
|
Medicare | 6 | 2022 | 6566 | 0.450 |
Why?
|
United States | 39 | 2023 | 69872 | 0.440 |
Why?
|
Drug Prescriptions | 3 | 2017 | 1637 | 0.440 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5751 | 0.420 |
Why?
|
Motivation | 1 | 2022 | 1971 | 0.410 |
Why?
|
Program Development | 2 | 2018 | 1316 | 0.410 |
Why?
|
Drug Monitoring | 1 | 2017 | 956 | 0.400 |
Why?
|
Computer Simulation | 4 | 2024 | 6196 | 0.340 |
Why?
|
Health Expenditures | 3 | 2017 | 2348 | 0.340 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2016 | 941 | 0.310 |
Why?
|
Community Mental Health Services | 1 | 2011 | 386 | 0.310 |
Why?
|
Health Services Needs and Demand | 2 | 2013 | 1411 | 0.310 |
Why?
|
Mental Health | 5 | 2022 | 3019 | 0.300 |
Why?
|
Patient Dropouts | 2 | 2011 | 421 | 0.300 |
Why?
|
Health Services Accessibility | 5 | 2023 | 5137 | 0.300 |
Why?
|
Florida | 4 | 2013 | 435 | 0.290 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4258 | 0.280 |
Why?
|
Health Policy | 4 | 2022 | 2661 | 0.280 |
Why?
|
Adult | 40 | 2024 | 214055 | 0.270 |
Why?
|
Psychiatry | 3 | 2015 | 1695 | 0.270 |
Why?
|
Primary Health Care | 6 | 2022 | 4558 | 0.260 |
Why?
|
Residence Characteristics | 1 | 2015 | 2050 | 0.250 |
Why?
|
Medically Underserved Area | 2 | 2024 | 253 | 0.250 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5391 | 0.240 |
Why?
|
Insurance Claim Review | 3 | 2014 | 720 | 0.230 |
Why?
|
Humans | 62 | 2024 | 744343 | 0.220 |
Why?
|
Family Practice | 1 | 2006 | 516 | 0.220 |
Why?
|
Foreign Medical Graduates | 1 | 2023 | 79 | 0.220 |
Why?
|
Ambulatory Care Facilities | 3 | 2021 | 933 | 0.220 |
Why?
|
Psychotic Disorders | 3 | 2016 | 3046 | 0.220 |
Why?
|
Haloperidol | 1 | 2023 | 397 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2014 | 3843 | 0.200 |
Why?
|
Contracts | 1 | 2021 | 60 | 0.200 |
Why?
|
Databases, Factual | 2 | 2016 | 7729 | 0.200 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3610 | 0.190 |
Why?
|
Polypharmacy | 2 | 2021 | 294 | 0.190 |
Why?
|
Physician Incentive Plans | 1 | 2022 | 161 | 0.190 |
Why?
|
Health Care Reform | 1 | 2010 | 1261 | 0.180 |
Why?
|
Reimbursement, Incentive | 2 | 2022 | 540 | 0.180 |
Why?
|
Health Services Research | 3 | 2022 | 1836 | 0.180 |
Why?
|
Off-Label Use | 1 | 2021 | 169 | 0.170 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3923 | 0.170 |
Why?
|
Middle Aged | 27 | 2023 | 213383 | 0.160 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2212 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2024 | 687 | 0.160 |
Why?
|
Benzodiazepines | 1 | 2023 | 1101 | 0.150 |
Why?
|
Health Status | 3 | 2018 | 4034 | 0.150 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.150 |
Why?
|
Confidence Intervals | 2 | 2013 | 2971 | 0.140 |
Why?
|
Forecasting | 2 | 2020 | 2951 | 0.140 |
Why?
|
Male | 31 | 2024 | 350118 | 0.140 |
Why?
|
Injections | 1 | 2018 | 840 | 0.130 |
Why?
|
Managed Care Programs | 1 | 2021 | 950 | 0.130 |
Why?
|
Female | 30 | 2024 | 380194 | 0.130 |
Why?
|
Patient Compliance | 1 | 2005 | 2684 | 0.120 |
Why?
|
Pennsylvania | 2 | 2017 | 613 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2009 | 15540 | 0.120 |
Why?
|
Psychomotor Agitation | 1 | 2016 | 293 | 0.120 |
Why?
|
Medicare Part C | 1 | 2018 | 296 | 0.120 |
Why?
|
Psychotherapy | 1 | 2003 | 1643 | 0.120 |
Why?
|
Minority Groups | 1 | 2021 | 1223 | 0.110 |
Why?
|
Psychotropic Drugs | 2 | 2018 | 894 | 0.110 |
Why?
|
Drug Utilization | 3 | 2015 | 1183 | 0.110 |
Why?
|
Episode of Care | 1 | 2014 | 126 | 0.110 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5319 | 0.110 |
Why?
|
Physicians | 2 | 2024 | 4567 | 0.100 |
Why?
|
Quality Indicators, Health Care | 2 | 2014 | 1831 | 0.100 |
Why?
|
Prediabetic State | 1 | 2017 | 499 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 7913 | 0.100 |
Why?
|
Heart Failure | 1 | 2015 | 10900 | 0.100 |
Why?
|
Bayes Theorem | 1 | 2019 | 2309 | 0.100 |
Why?
|
New York | 3 | 2019 | 886 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2003 | 2838 | 0.100 |
Why?
|
Cohort Studies | 6 | 2017 | 40561 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 25043 | 0.090 |
Why?
|
Value of Life | 1 | 2010 | 97 | 0.090 |
Why?
|
Odds Ratio | 2 | 2013 | 9849 | 0.090 |
Why?
|
Conflict of Interest | 1 | 2015 | 544 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2003 | 3748 | 0.090 |
Why?
|
Hospitalization | 2 | 2018 | 10262 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.090 |
Why?
|
Caribbean Region | 1 | 2010 | 194 | 0.090 |
Why?
|
Utilization Review | 1 | 2011 | 392 | 0.090 |
Why?
|
Cost Savings | 1 | 2015 | 926 | 0.090 |
Why?
|
Case Management | 1 | 2011 | 286 | 0.090 |
Why?
|
Weight Gain | 1 | 2019 | 2292 | 0.080 |
Why?
|
Veterans Health | 1 | 2011 | 216 | 0.080 |
Why?
|
Adolescent | 10 | 2021 | 85781 | 0.080 |
Why?
|
Latin America | 1 | 2010 | 381 | 0.080 |
Why?
|
Fee-for-Service Plans | 1 | 2014 | 694 | 0.080 |
Why?
|
Sex Factors | 3 | 2016 | 10397 | 0.080 |
Why?
|
United States Department of Veterans Affairs | 2 | 2010 | 875 | 0.080 |
Why?
|
Young Adult | 8 | 2021 | 56430 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3218 | 0.080 |
Why?
|
Financing, Personal | 1 | 2010 | 308 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2013 | 681 | 0.080 |
Why?
|
Sex Distribution | 1 | 2013 | 2297 | 0.080 |
Why?
|
Alcoholism | 1 | 2018 | 1906 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2020 | 63114 | 0.070 |
Why?
|
Models, Organizational | 1 | 2010 | 574 | 0.070 |
Why?
|
Tooth Diseases | 1 | 2007 | 77 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12245 | 0.070 |
Why?
|
Veterans | 2 | 2011 | 2519 | 0.070 |
Why?
|
Probability | 1 | 2011 | 2505 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.070 |
Why?
|
Financing, Government | 1 | 2009 | 468 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2003 | 6038 | 0.060 |
Why?
|
Medical Records | 1 | 2011 | 1413 | 0.060 |
Why?
|
Chronic Disease | 2 | 2011 | 9146 | 0.060 |
Why?
|
Choice Behavior | 2 | 2014 | 803 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3022 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
Tennessee | 1 | 2023 | 117 | 0.060 |
Why?
|
Age Factors | 2 | 2015 | 18370 | 0.060 |
Why?
|
Periodontal Diseases | 1 | 2007 | 449 | 0.060 |
Why?
|
Aged | 7 | 2021 | 163280 | 0.060 |
Why?
|
Hospitals | 1 | 2016 | 3952 | 0.050 |
Why?
|
Insurance Claim Reporting | 1 | 2003 | 163 | 0.050 |
Why?
|
State Medicine | 1 | 2024 | 217 | 0.050 |
Why?
|
Prevalence | 2 | 2017 | 15226 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2518 | 0.050 |
Why?
|
Oregon | 1 | 2021 | 140 | 0.050 |
Why?
|
Drug Costs | 1 | 2009 | 1105 | 0.050 |
Why?
|
Attitude to Health | 1 | 2010 | 2052 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2003 | 434 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2024 | 1005 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.050 |
Why?
|
Expert Testimony | 1 | 2003 | 356 | 0.050 |
Why?
|
Needs Assessment | 1 | 2006 | 1147 | 0.040 |
Why?
|
Lithium | 1 | 2003 | 601 | 0.040 |
Why?
|
Models, Statistical | 2 | 2024 | 5102 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
Employment | 1 | 2006 | 1132 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2014 | 13989 | 0.040 |
Why?
|
Social Adjustment | 1 | 2001 | 631 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7659 | 0.040 |
Why?
|
Psychological Techniques | 1 | 2018 | 45 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2003 | 1344 | 0.040 |
Why?
|
Research Personnel | 1 | 2003 | 573 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15165 | 0.040 |
Why?
|
Child | 4 | 2016 | 77709 | 0.040 |
Why?
|
Health Care Rationing | 1 | 2021 | 437 | 0.040 |
Why?
|
Family Health | 1 | 2001 | 1282 | 0.030 |
Why?
|
Markov Chains | 1 | 2019 | 969 | 0.030 |
Why?
|
New York City | 1 | 2018 | 710 | 0.030 |
Why?
|
Patient Care | 1 | 2021 | 640 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 170 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10388 | 0.030 |
Why?
|
Patient Care Management | 1 | 2018 | 306 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1049 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13408 | 0.030 |
Why?
|
Group Practice | 1 | 2013 | 149 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2003 | 2708 | 0.030 |
Why?
|
General Practice | 1 | 2013 | 100 | 0.030 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2011 | 92 | 0.020 |
Why?
|
Medical Audit | 1 | 2011 | 467 | 0.020 |
Why?
|
Education, Continuing | 1 | 2010 | 112 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2007 | 5027 | 0.020 |
Why?
|
Time | 1 | 2010 | 542 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2005 | 19905 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3528 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2006 | 4644 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39050 | 0.020 |
Why?
|
Length of Stay | 1 | 2001 | 6309 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 2010 | 404 | 0.020 |
Why?
|
Dental Health Surveys | 1 | 2007 | 43 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6459 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Ichthyosis | 1 | 2007 | 60 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 1994 | 1678 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 500 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2009 | 812 | 0.020 |
Why?
|
Research Design | 1 | 2001 | 5987 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5255 | 0.020 |
Why?
|
Neurology | 1 | 2013 | 763 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1405 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1953 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40075 | 0.010 |
Why?
|
Oral Health | 1 | 2007 | 472 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2005 | 1254 | 0.010 |
Why?
|
Health Surveys | 1 | 2010 | 4037 | 0.010 |
Why?
|
Suicide | 1 | 2009 | 1477 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
Pediatrics | 1 | 2013 | 3475 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 41006 | 0.010 |
Why?
|
Defense Mechanisms | 1 | 1994 | 178 | 0.010 |
Why?
|
Treatment Refusal | 1 | 1994 | 421 | 0.010 |
Why?
|
Observer Variation | 1 | 1994 | 2593 | 0.000 |
Why?
|
Incidence | 1 | 2005 | 20947 | 0.000 |
Why?
|
Psychometrics | 1 | 1994 | 3002 | 0.000 |
Why?
|
Family | 1 | 1994 | 3147 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2007 | 57776 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 11725 | 0.000 |
Why?
|
Physician-Patient Relations | 1 | 1994 | 3229 | 0.000 |
Why?
|